Patients with heart failure with preserved ejection fraction (HFpEF) experience elevated filling pressures and reduced ventricular compliance. The splicing factor RNA-binding motif 20 (RBM20) regulates the contour length of titin's spring region and thereby determines the passive stiffness of cardiomyocytes. Inhibition of RBM20 leads to super compliant titin isoforms (N2BAsc) that reduce passive stiffness.
G
reater than half of all heart failure (HF) patients experience increased diastolic stiffness and impaired relaxation of the left ventricle (LV) while their ejection fraction (EF) is preserved (HFpEF). 1 HFpEF is a complex syndrome that includes diastolic dysfunction, exercise intolerance, and concentric hypertrophic remodeling. 2, 3 No effective therapies exist for treating this pervasive syndrome due in part to the limited understanding of the underlying pathophysiology. HFpEF is likely because of a range of pathomechanisms that include dysfunction in sarcomeric proteins and slowing of the early phase of diastole that might be caused by changes in calcium handling/response proteins. Titin, the largest known protein and molecular spring in the heart, has emerged as a prime therapeutic target aimed at restoring compliance to the sarcomere and thereby improving diastolic function. 4 The titin gene (TTN) contains 364 exons that encode the third myofilament of the sarcomere that spans from Z-disk to M-band. 5 Titin's I-band region acts as a molecular spring that is responsible for maintaining the structural integrity of the sarcomere. 6 In addition, titin's molecular spring is the chief contributor of passive stiffness in the heart and functions as a mechanosensor for stress and strain in the myocyte. 7 Alternative splicing produces 2 main cardiac isoforms: the smaller N2B isoform (≈3.0 MDa) and the larger more compliant N2BA isoform (≈3.3 MDa). Diastolic stiffness of the LV is in large part dependent on the N2BA:N2B isoform ratio. 8 Stiffness can also be tuned through post-translational modification of these primary isoforms, particularly through phosphorylation of titin's spring region. [9] [10] [11] Post-translational modification of titin's spring region is deranged in patients with HFpEF, 4, 12 which contributes to increased diastolic stiffness. Because protein kinase G phosphorylation of titin's N2B element enhances spring compliance, targeted treatment of HFpEF by enhancing protein kinase G activity with the phosphodiesterase 5 inhibitor sildenafil was performed (summarized in the recent RELAX trial [PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure]) 13 ; however, exercise capacity was unimproved and clinical outcomes were similar to placebo. 13 Another potential therapeutic approach is upregulation of compliant titin isoforms. Alternative splicing of messenger RNA occurs primarily in transcripts encoding the spring region of titin and therefore regulates the elastic properties of titin through changes in contour length of the spring. Because the discovery of RBM20 as a titin-splicing factor, 10 modification of titin size through RBM20 inhibition has become possible.
This study evaluates whether manipulating post-transcriptional modification of titin isoforms through the reduction of the titin-splicing factor RBM20 that has a beneficial effect on the diastolic function of mice with restrictive cardiomyopathy. A previously published mouse model 14 deficient in titin's IA junction (Ttn ΔIAjxn ) places increased strain on the spring region of titin.
The Ttn
ΔIAjxn mouse is a choice tool for studying diastolic dysfunction because this model displays similar phenotypic characteristics found in the patients with HFpEF, notably diastolic dysfunction, reduced exercise tolerance, and concentric remodeling of the LV chamber in response to stress. Furthermore, all known signaling elements in titin remain intact and therefore the pathology can be attributed solely to increase in titin-based strain. We aimed to determine whether the inhibition of RBM20 could recover function in this model back to a wild-type (WT) state. Our data establish that inhibiting titin-splicing factor RBM20 in the Ttn ΔIAjxn mouse improves diastolic function, restores exercise tolerance, and attenuates afterload-induced pathological concentric remodeling.
Methods

Generation of Mice Homozygous for Ttn
ΔIAjxn and Heterozygous for Cardiac-Specific cRbm20 ΔRRM We bred 2 murine models, the Ttn ΔIAjxn14 and the cardiac-specific α-myosin heavy chain (α-MHC) Cre cRbm20 ΔRRM , 14 to compare the effects of increased or decreased strain in titin, respectively. To study the effect of RBM20 inhibition in 28 (from start of injections), mice were examined by echo and catheterization and then euthanized. Hearts were dissected, weighed, and flash frozen at −80°C for further titin isoform analysis using standard procedures (Online Methods section). Western blot studies with an antibody to RBM20's C terminus 11 revealed that the LV of the α-MHC-Cre ΔIAjxn/ΔRRM expresses 40% of the total RBM20 as mutant protein; for the MCM ΔIAjxn/ΔRRM mice, this value is 45% mutant RBM20 ( Figure 1B ). Experiments were approved by the University of Arizona Institutional Animal Care and Use Committee and followed the US National Institutes of Health.
Using Animals in Intramural Research Guidelines for Animal Use
Protein Expression Analysis
Protein expression analysis was performed by using standard titin gel electrophoresis methods.
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Cell Mechanics
Skinned cardiac myocyte mechanics were performed as previously reported (see Online Methods section for details).
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Hemodynamics
Anesthetized and conscious echocardiography was performed on mice, and pressure volume relations were evaluated using cardiac catheterization. Diastolic function was assessed in mice using continuous flow 2% isoflurane inhaled anesthetic with a target heart rate of 450±25 bpm (see Online Methods section for details).
Exercise Performance
Exercise tolerance was evaluated by measuring time and distance ran using a treadmill running test (see Online Methods section for details).
Transverse Aortic Constriction Surgery
Male mice 3 to 4 months old were subjected to minimally invasive transverse aortic constriction (TAC) 17 performed under ketamine/xylazine (120/12 mg/kg) anesthesia; details are explained in the Online Methods section. Briefly, a 27-gauge needle was used for banding, and mice were studied by echocardiography at 28 days and then euthanized. Hearts were immediately dissected, weighed, and frozen for further analysis.
Myocyte Cross-Section Area
Cross-sectional area of cardiomyocytes was performed as described 18 with minor modifications. Hearts in diastole were removed from sham and TAC mice, and the LV tissue was covered with OCT (Tissue-Tek) and frozen with liquid nitrogen-cooled isopentane and stored at −80°C; 8-μm thick sections were collected on VWR glass microscope slides and stored at −20°C overnight. The crosssections were skinned and stained with anti-Laminin (Sigma) to demarcate cell borders and DAPI (4',6-diamidino-2-phenylindole; Vector Laboratories) to stain nuclei. Images were collected on an Axio Imager M.1 microscope (Carl Zeiss) using an Axio Cam MRC (Carl Zeiss). Cross-sectional areas were measured using the ImageJ program (National Institutes of Health) and their borders of stained cells that included nuclei were traced manually. The cross-sectional area of 100 myocytes from the myocardium of the LV (6 mice per group) were collected from each sample using 4 randomly selected sections.
Statistics
Statistical analysis was performed in Graphpad Prism (GraphPad Software, Inc). Group significance was defined using 1-or 1-way ANOVA followed by multiple testing correction, as appropriate. Results are shown as mean±SEM. P<0.05 was considered significant. Figure 2A ) but have normal expression of the adult N2B and N2BA isoforms. However, both isoforms are reduced in size as revealed by their slight increase in mobility in gel electrophoresis (compare Figure 2B left and middle lanes). The larger and more compliant N2BA isoform (≈3.3 MDa in WT and ≈3. 15 
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MDa in Ttn
ΔIAjxn
) comprises ≈ 20% of total titin in both WT and Ttn ΔIAjxn mice ( Figure 2C , left and middle bar, Online Table I ). It was recently shown that as a consequence of deleting the IA junction of titin, the attachment point of titin's spring region is moved away from the Z-disk, resulting in greater titin strain in Ttn ΔIAjxn mice.
14 cRbm20 ΔRRM mice (α-MHC-Cre) are deficient in titinsplicing factor RBM20 and, as previously described, 11 they upregulate large N2BA titin isoforms that we refer to as super compliant titin (N2BAsc). To determine the therapeutic potential of RBM20 inhibition, we bred Ttn ΔIAjxn mice with α-MHC-Cre cRbm20 ΔRRM mice to produce Ttn ΔIAjxn mice that are heterozygous deficient in splicing factor RBM20 (see Online Figure I , left for more detail on the breeding scheme and Online Table II Figure 2B , right lane) encompassing ≈80% of total titin in the murine LV ( Figure 2C ; Online Table I ). Thus, heterozygous inhibition of the titin-splicing factor RBM20 is highly effective in upregulating compliant titin.
Previously, we have shown that altering titin size and therefore strain on titin's spring region directly affects passive stress in skinned LV cardiomyocytes. 14 We tested whether inhibiting RBM20 in Ttn ΔIAjxn mice reduces the elevated diastolic stress in skinned myocytes to WT levels. Cardiomyocytes were skinned and isolated in relaxing solution, and cells were attached at one end to a force transducer and at the other end to a servomotor and subjected to a stretch-hold-release protocol using standard procedures (see Online Methods section for details). Passive stress was significantly increased in Ttn ΔIAjxn mice but was normalized in Ttn ΔIAjxn mice expressing super compliant titin ( Figure 2D ). Passive stiffness (slope of stresssarcomere length relation within physiological sarcomere length range) was similarly reduced to WT levels ( Figure 2E ).
Reduction of RBM20 Expression Restores Diastolic Function to Ttn
ΔIAjxn Mice
Results at the cellular level were further evaluated at the organ level to assess cardiac function in diastole ( Figure 3 ). Pulse-wave Doppler in the 4-chamber apical view revealed significant differences in mitral valve deceleration time and left ventricular pulse-wave Doppler E-wave:A-wave ratio (E/A) ratios of Ttn ΔIAjxn mice compared with WT control, indicating diastolic dysfunction (Figure 1C and 3D 19 The mitral valve deceleration time was found to be at WT levels (26.5±1.5 ms) Table) . Occlusion of the inferior vena cava allowed us to determine the steepness of the end-diastolic pressure-volume relationship (EDPVR), β, which is a load-independent parameter. The EDPVR (β) is the coefficient of stiffness in the LV and was found to be (0.03±0.004 mm Hg/μL) in WT mice. Ttn ΔIAjxn mice had an elevated EDPVR (β) of 0.08±0.01 mm Hg/μL that was normalized in Ttn ΔIAjxn mice expressing N2BAsc titin (0.02±0.002 mm Hg/μL). Therefore, consistent with our skinned cell experiments, compliance in the LV chamber was recovered in Ttn ΔIAjxn mice deficient in splicing factor RBM20.
We further examined diastolic recovery of Ttn ΔIAjxn mice with inducible (α-MHC-MCM) cRbm20
ΔRRM mice that express N2BAsc on a Ttn ΔIAjxn background (see breeding scheme in Online Figure I , right for further details). This evaluation is important because it allows us to test whether diastolic dysfunction, once it has occurred, is recoverable therapeutically by upregulating compliant titin. Inducible mice were echoed at day 0 and then injected intraperitoneally for 8 days with either vehicle or selective estrogen receptor modulator raloxifene (see Methods for additional details, and see Online Table III for raloxifene control experiments). After 8 days of raloxifene injections, >60% of N2BAsc titin expression occurred at 28 days ( Figure 1A ; Online Figure II) . To evaluate the expression levels of mutant and WT RBM20, we used an antibody raised We used this antibody on LV samples of constitutive (α-MHC ΔIAjxn/ΔRRM) and inducible (α-MHC-MCM ΔIAjxn/ΔRRM) models. Because the mice were heterozygous for the ΔRRM allele, mutant RBM20 is expected to make up 50% of total protein. However, there is slightly <50% mutant RBM20 ( Figure 1B , bottom), indicating upregulation of WT RBM20 in the heterozygous mice. Furthermore, the samples from inducible ΔIAjxn/ΔRRM mice have a higher level of mutant RBM20 (45% of total) than the constitutive mice (40%), suggesting that the degree of upregulation of WT RBM20 is higher in the inducible mice. These results combined with the protein, and functional data suggest that inactivating ≈40% to 45% of total RBM20 results in robust upregulation of super compliant titin. Inducible (α-MHC-MCM ΔIAjxn/ΔRRM) mice were echoed at day 28 to assess diastolic function and then evaluated with a terminal cardiac catheterization procedure for studying the effect of expressing N2BAsc titin. Similar to our constitutive model (α-MHC ΔIAjxn/ΔRRM), diastolic function was improved as shown by pulse-wave Doppler revealing a greater duration of the mitral valve deceleration time and a significant reduction in the E/A ratio ( Figure 1C and 1D) . Moreover, pressure-volume analysis showed significant improvement of the EDPVR (β) on the induction of N2BAsc expression ( Figure 1E ). Systolic function was unaltered between vehicle and treatment groups (Online Table IV ). In addition, WT controls undergoing the same protocol of raloxifene treatment were evaluated by echo and systolic function was unaffected (Online Table III ). Thus, acutely reducing strain in titin has a beneficial effect on the diastolic function of the stiff LV.
Assessment of Associated HFpEF Symptoms
Similar to patients with HFpEF, 21, 22 Ttn ΔIAjxn mice display exercise intolerance. 14 We tested whether upregulating compliant titin has a beneficial effect on exercise tolerance by submitting mice to incremental speed running on a treadmill. Mice with compliant titin ran longer and for a greater distance in both the constitutive ( Figure 4A and 4B) and the inducible N2BAsc expressing models ( Figure 4C and 4D) . Overall, these findings suggest that increasing titin compliance in the heart has a beneficial effect on exercise performance in the Ttn ΔIAjxn murine model. In addition to exercise intolerance, concentric remodeling in the heart is a common clinical manifestation in patients with HFpEF. 23 We, therefore, tested the responsiveness of mice with differing strain in titin to afterload stress. Mice were subjected to minimally invasive TAC surgery, a procedure widely used to elicit afterload-dependent hypertrophic remodeling in the LV. Compared with WT mice, Ttn ΔIAjxn mice displayed an exaggerated hypertrophic response to TAC (P=0.0001), whereas the LV hypertrophy response in Ttn ΔIAjxn mice expressing N2BAsc titin was attenuated compared with Ttn Figure 5A ). The degree of remodeling these mice experienced in the LV was determined by measuring the LV enddiastolic diameter and the wall thickness in diastole. These parameters were obtained using M-mode echocardiography of the LV in the short-axis view. By calculating wall thickness/ LV end-diastolic diameter, we can assess the degree to which the LV is concentrically remodeled in response to TAC. Robust concentric remodeling after 4 weeks of pressure overload was observed in WT and Ttn ΔIAjxn mice with the largest values in Ttn ΔIAjxn mice; however, remodeling was lessened significantly in Ttn ΔIAjxn mice expressing N2BAsc titin ( Figure 5B ; see also Online Figure III with cross-sectional area analysis) . In addition to reduced pathological remodeling, Ttn ΔIAjxn mice with upregulated compliant titin also exhibited better diastolic function as revealed by Doppler imaging (Figure 5C through  5D ). This data suggest that varying the length of titin isoforms alters the responsiveness to pressure overload hypertrophy in the heart and that increasing titin compliance is advantageous for preventing diastolic dysfunction associated with afterloadinduced concentric remodeling of the heart.
ΔIAjxn
Discussion
We report for the first time a rescue of HFpEF-like symptoms in the mouse through inhibition of the titin-splicing factor RBM20.
The Ttn
ΔIAjxn murine model acts as a mechanical analog of the titin-based increase in passive myocardial stiffness found in patients with HFpEF. 4 Increased passive stiffness is present in the adult Ttn ΔIAjxn mouse, in the absence of pharmacological or surgical intervention. By using the Ttn
ΔIAjxn mouse as a model of HFpEF, we demonstrate that inhibiting RBM20 restores diastolic function, improves exercise tolerance, and attenuates afterload-induced pathological remodeling of the LV. Because of our still limited understanding of HFpEF pathophysiology, there are no specific therapies to treat this widespread disease; therefore, our findings on RBM20 inhibition are clinically significant. Cardiac titin's I-band region is a ≈1.0 MDa spring composed of 3 distinct elements: the tandemly arranged immunoglobulinlike element, the cardiac-specific N2B element, and the proline, glutamate, valine, and lysine-rich element. 24 During diastole, stretch occurs in titin's spring region and this provides elasticity to the sarcomere. 25 Alternative splicing of titin occurs predominantly in the spring region and is responsible for the variances found in the 2 main adult cardiac isoforms of titin, N2B and N2BA. 26 The more compliant N2BA isoform has a longer extensible spring region owing to the longer proline, glutamate, valine, and lysine and Ig segments. The N2B isoform is the dominant isoform in both mice and men, with human LV expressing N2B and N2BA isoforms at a ratio of ≈60:40. 4, 27 Both isoforms extend the same distance for a given sarcomere length (near Z-disk to beginning of A-band); however, the force to stretch titin is greater in the N2B isoform attributable to its shorter contour length. 8 By reducing the level of functional RBM20 protein, additional exon incorporation into titin's spring elements minimizes passive stiffness in a manner inversely related to the size of titin.
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The Ttn
ΔIAjxn murine model has 18 exons deleted from the mouse Ttn gene that encode 3 Ig domains and 11 FnIII domains that constitute a 153-kDa polypeptide fragment in titin known as the I-band-A-band junction. This model is unique from previously ); E/A, left ventricular pulse-wave Doppler E-wave:A-wave; EA, arterial elastance; EDP, end-diastolic pressure; EDPVR, enddiastolic pressure-volume relationship; EDV, end-diastolic volume; EF, ejection fraction; ESP, end-systolic pressure; ESPVR, end-systolic PV relationship; ESV, end-systolic volume; FS, fractional shortening; IAjxn, I-band-A-band junction; LA, left atrium; LVDD, left ventricular end-diastolic diameter; LVIDd, LV internal diastolic diameter; LVIDs, LV internal systolic diameter; LVPWs, LV posterior wall thickness in systole; MV, mitral valve; SV, stroke volume; and WT, wild-type. *Indicates significance vs WT; *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001; †indicates significance vs Ttn published titin I-band truncation models (N2B, 28 proline, glutamate, valine, and lysine, 29 and Ig 16 ) in that the entire spring region of titin remains intact, including all spring element phosphosites. Removal of titin's IA junction results in anchoring of the C-terminal attachment of titin's distal Ig spring element further away (≈70 nm) from the Z-disk, resulting in enhanced strain in titin's spring region and consequently an increase in force per titin molecule.
14 This increased force mimics the pathological conditions of oxidative stress and deranged phosphorylation evident in patients with HFpEF. 4, 30 Interestingly, the Ttn ΔIAjxn mouse recapitulates many characterisitcs of HFpEF, for example, diastolic dysfunction, exercise intolerance, and hypertrophy. Herein, we studied whether reducing functional RBM20 expression ameliorates these symptoms.
Evaluation of Ttn
ΔIAjxn mice with and without N2BAsc expression was performed at the cell and organ levels. The increased stiffness of cardiac myocytes from Ttn ΔIAjxn mice ( Figure 2E ) are in agreement with previous reports showing that altering the size of titin directly affects passive stiffness. 11, 14 That this causes increased LV chamber stiffness is supported by multiple chamber-level measurements. The greater ratio of the early mitral inflow (E) to late atrial kick (A) revealed by pulse-wave Doppler imaging is indicative of increased diastolic stiffness ( Figure 3C ). Moreover, LV chamber stiffening abbreviates the time of deceleration of the early mitral inflow 31 and the reduced deceleration time in Ttn ΔIAjxn mice ( Figure 3D ) also support restrictive filling. In accordance with echocardiography, cathererization of the LV revealed a steeper slope of the EDPVR demonstrating diastolic stiffness in the LV of Ttn ΔIAjxn mice. Remarkably, inhibiting RBM20 both chronically and acutely in Ttn ΔIAjxn mice restored these parameters back to WT levels (Figures 1 and 3) . Assessing inducible expression of compliant titin is imperative because patients with HFpEF typically develop symptoms later in adult life; therefore, an acute therapy to restore diastolic function in the elderly HFpEF patient is necessary. On inducing compliant titin isoform expression in Ttn ΔIAjxn mice, diastolic dysfunction was corrected and these mice preformed better in exercise tolerance studies (as further discussed below). Thus, our hemodynamic studies in mice with inhibited RBM20 suggest that this intervention is beneficial for restoring compliance to the restrictive LV.
The advantage of RBM20 inhibition was further evidenced by exercise testing. Exercise is considered a beneficial therapy in patients with heart failure, 32 but how titin compliance relates to exercise capacity is not well understood. Because our models are cardiac specific for RBM20 reduction, we could assess exercise performance because it directly relates to increasing the strain in cardiac titin. A limitation to note is that the Ttn ΔIAjxn mouse deletes the IA junction in both skeletal and cardiac muscles (it is a global KO) and that future control studies are necessary to test exercise tolerance in a cardiac-specific Ttn performed significantly better than those that did not (vehicle control). Exercise intolerance leading to fatigue and shortness of breath has a major impact on the quality of life in patients with HFpEF; therefore, our finding of improved exercise performance through upregulating titin compliance is encouraging.
Titin has been hypothesized to function as biomechancial sensor and our present studies support that titin mechanosensation contributes to increased afterload-induced LV hypertrophy. We constricted the transverse aorta of mice to induce acute pressure overload stress to the heart. Compared with WT controls, Ttn ΔIAjxn mice exhibited a 50% greater increase in LV mass characterized by robust concentric remodeling ( Figure 5 ). In contrast, RBM20-inhibited Ttn ΔIAjxn mice (with reduced titin strain) had the least amount of LV mass increase in response to TAC ( Figure 5A ). Hypertrophy signaling in the myocyte is extremely complex, 33 and mechanotransduction remains incompletely understood. We explored a previously proposed titin-based signal transduction mechanisms that involved the titin-binding proteins, four and a half LIM domain 1 (FHL1) and FHL2. FHL proteins are expressed in striated muscle where they facilitate diverse protein-protein interactions involved in signal transduction. 34 Previous studies have shown localization of FHL1 and FHL2 at the N2B element in titin. 35, 36 Furthermore, the regulation of extracellular signal-regulated kinase 2 has been reported by both FHL1 and FHL2 in cardiomyocytes. 37, 38 It has also been reported that in response to pressure oveload, FHL1 null mice display an attenuated hypertrophy response, 35 whereas the TAC response of FHL2 null mice does not significantly differ from WT. 34 Our data are in agreement with these findings because FHL1 is significantly upregulated and FHL2 protein levels remain unaltered in response to TAC (Online Figure IV) . Thus, FHL1 might be involved in the increased hypertrophy response in the Ttn ΔIAjxn model and its normalization when N2BAsc is expressed. Further studies are necessary to investigate titin as a sensor for mechanotransduction, including the roles of FHL1 and FHL2.
HFpEF is a complex disease with multiple pathogeneses that induce restrictive filling in the LV of which titin-based stiffening is likely to be only one of several underlying causes. Our present work revealed that increasing the compliance of titin's spring region has a beneficial effect on diastolic function of the heart in a titin-specific HFpEF mouse model. Patients with HFpEF experience diastolic dysfunction that leads to a myriad of symptoms, including exercise intolerance and reduced quality of life. 39 Innovative therapies are urgently needed to address diastolic stiffness, and our study reveals novel insights into the pathophysiology of HFpEF and the central role played by titin. Lengthening the spring region of titin through alternative splicing reduces passive myocardial stiffness and improves a HFpEF-like phenotype in the Ttn ΔIAjxn mouse. Diastolic function was recovered both chronically and acutely resulting in an enhanced exercise performance compared with littermate controls. Furthermore, afterload-induced pathological remodeling was attenuated in mice expressing N2BAsc titin. Future efforts should be focused on testing RBM20 inhibition in larger animal models to determine how much inhibition is required to achieve benefit in diastolic function without causing side effects, especially when inhibition of RBM20 is long-term. In summary, our work supports that ameliorating diastolic dysfunction and pathological chamber remodeling might be achievable through therapeutically targeting titin.
What Is Known?
• Tuning mechanisms in the elastic protein titin that alter titin's compliance are deranged in heart failure patients with preserved ejection fraction (HFpEF).
• The titin-based murine model Ttn
ΔIAjxn has increased diastolic stiffness and HFpEF-like symptoms (diastolic dysfunction and exercise intolerance).
• RBM20, a splicing factor of titin, regulates the compliance of titin in a dose-dependent manner.
What New Information Does This Article Contribute?
• Reduction of RBM20 by 40% to 45% in Ttn ΔIAjxn mice is sufficient to greatly increase titin compliance.
• Reduction of RBM20 in Ttn ΔIAjxn mice recovers diastolic function, and improves exercise tolerance and pressure overload-induced ventricular remodeling. 
Generation of Mice: Ttn
ΔIAjxn and Rbm20 ΔRRM mice previously described 1, 2 were bred to generate homozygous Ttn ΔIAjxn mice on that were heterozygous for WT RBM20 protein on a C57BL/6J background. In our studies we used mice 4 months old and male, unless indicated otherwise (see Figure S1 for breeding details). All experiments were approved by the Myocyte suspension was added to a room temperature flow-through chamber mounted on the stage of an inverted microscope (Diaphot 200; Nikon). Skinned myocyte was glued at one end to a force transducer (Model 406A or 403A, Aurora Scientific). The other end was bent with a pulled glass pipette attached to micromanipulator so that the myocyte axis aligned with the microscope optical axis and cross sectional area (CSA) was measured directly.
The cross sectional images of skinned cells were analyzed by ImageJ 1.41 software (National Institutes of Health)
and were used to convert measured force to stress and for cell dimension study (Fig S4d) . Then, the free end of the cell was glued to a servomotor (Model 308B, Aurora Scientific) that imposes controlled stretches. Sarcomere 
Pressure-Volume Analysis:
In vivo pressure-volume analysis was performed in mice using a SciSense
Advantage Admittance Derived Volume Measurement System and 1.2F catheters with 4.5 mm electrode spacing (SciSense, London, Ontario, Canada). Mice were anesthetized and ventilated with 1.5% isoflurane using a SAR-1000 Small Animal Ventilator (CWE). Body temperature under anesthesia was maintained at 37°C using a TC-1000 Temperature Controller (CWE). A lateral incision through the skin and muscle was made below the ribcage and the diaphragm was cut in order to expose the apex of the heart. A small puncture was made in the apex of the left ventricle using a 28G needle and the 1.2F catheter was inserted into the LV. Baseline functional parameters
were assessed during a pause in ventilation in order to avoid respiratory influences. For load-independent indices, including the end-systolic and end-diastolic pressure-volume relationships, the IVC was temporarily occluded to vary the preload conditions. Data acquisition and analysis was performed using LabScribe 2 (iWorx, Dover, NH) and curve fitting was performed with MATLAB (MathWorks, Natick, MA). Diastolic PV data was analyzed using a mono-exponential fit with constant (P = Ae βV + C) with the exponent (β) reported as the coefficient of stiffness.
Exercise Testing: Mice were tested for maximal running speed using a 6-lane rodent treadmill system (Exer 3/6, Columbus Instruments, Columbus, OH). After an acclimation period during which mice were running at low speed (10 m/min), exercise testing was performed by having mice run at progressively increasing speeds (speed steps of 4 m/min). Maximal speed was determined when the mouse left the treadmill and remained on a shock pad for at least 5 sec. Western Blotting: The solubilized samples were run on SDS PAGE gels (different percentages depending on target protein). Gels were run for approximately 2 hours then samples were transferred to PDVF membranes (Immobilon, Millipore) using a semi-dry transfer unit (Trans-Blot Cell, Bio-Rad). Transfer amperage was based on area of membrane(s) multiplied by 1.3 and was run for 2.5hours. The membranes were stained with Ponceau S (Sigma) to visually ensure protein transfer. The Ponceau S stain was later removed by .1M NaOH, and blots were placed in a blocking solution (Odyssey Block) for 1hour to prevent non-specific binding of the antibody.
Quantification of Protein Expression
Blocking solution was removed and blots were then soaked in the primary antibody solution overnight. Primary antibody was removed and blots were washed with PBS-tween solution before secondary fluorescent antibody was added. The blots soaked in secondary antibody for 1hour before they were scanned using an Odyssey Infrared
Imaging System (Li-COR Biosciences). Images obtained were analyzed using Li-COR Odyssey software.
Transverse Aortic Constriction: For minimally invasive Transverse Aortic Constriction (TAC) surgeries, anesthesia was induced by intraperitoneal (i.p.) injection of ketamine hydrochloride (120 mg/kg) plus xylazine (12 mg/kg) for a depth of anesthesia ~45 min, long enough to finish the surgery. The aortic banding procedure was performed similar to that previously described in 5 with minor adaptations. Briefly, a small incision in the chest cavity was created between the first and second intercostal ribs and the transverse portion of the aorta was bluntly dissected from the surrounding tissue. A curved forceps was then placed under the transverse aorta, 7-0 silk was grasped by the forceps and moved underneath the aorta between the right innominate and left carotid arteries, and a loose double knot was made. A 27-gauge needle with OD 0.42 mm was delivered through the loose double knot and placed directly above and parallel to the aorta. The loop was then tied around the aorta and needle and secured with the second knot (this was done very quickly, to minimize ischemia). The needle was immediately removed to provide a lumen with a stenotic aorta. Following the surgery, all layers of muscle and skin were closed with 6-0 continuous absorbable and nylon sutures, respectively, and the wound was treated with Betadine.
Immediately after the operation, 0.5 ml of 37°C saline was given intraperitoneally, and a dose of analgesic (SRbuprenorphine, 0.1 mg/kg) was also given subcutaneously. For the sham operation (control) the mice underwent the identical procedure, except placing of the ligature. The surgical survival rate following TAC was >90% and mortality rate within the first month following TAC was low (<5%). Successful surgical ligation of the transverse aorta, determined by a Doppler flow velocity measurement indicated by a large pressure gradient following constriction. Animals were sacrificed, weighed and cardiac tissue was flash frozen in liquid nitrogen (-80⁰C) for further analysis.
Myocyte Cross Section Area: Cross-sectional area (CSA) of cardiomyocytes was performed as described 6 
